Purpose
to fund development of GMP biological materials and GMP process for producing sIPV bulk on the NevoLine manufacturing platform and fund tech transfer of the GMP enabled platform to a DCVM partner
Grantee
Division
Global Development,
Global Health
Date
NOVEMBER 2018
Region served
GLOBAL
Committed amount
$11,809,256
Grant topic
Polio,
Vaccine Development
Duration (months)
56
Grantee location
Leiden, Zuid-Holland, Netherlands
More about our work
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.